MOMENTUM 2026

Accelerating Europe´s action on cancer.

Read more

Accelerating Europe´s action on cancer.

Read more

Marking 75 years of advancing cancer research, the Swedish Cancer Society hosted Momentum 2026 – an international conference focused on accelerating Europe's translation of cancer research into patient benefit. 

Momentum took place on 14–16 October at Artipelag in Stockholm, Sweden, bringing together participants from across Europe for a three-day, in-person conference.

"Patients’ needs and perspectives must be at the heart of everything we do."

Momentum demonstrated the value of bringing together people from across the cancer community, including researchers, healthcare professionals, policymakers, patient organisations, industry, investors and funders, each bringing different perspectives and expertise. What struck me most was not only the depth of knowledge in the room, but also the willingness to challenge established ways of working and explore new solutions. 

 The discussions showed what Europe could achieve through stronger cross-border clinical research, better use of health data and greater investment in cancer research and innovation. By working more closely together, we can accelerate the development of new treatments and help more patients benefit from scientific advances. Throughout the conference, one message remained clear: patients’ needs and perspectives must be at the heart of everything we do.

Europe has enormous expertise and commitment. Now we need to build on these strengths and turn collaboration into real progress for patients. I believe Momentum brought us closer to that goal. Seeing the energy and commitment of participants, panellists, speakers and the Momentum working group makes me both proud and hopeful.

Ultimately, progress must be measured not only by scientific breakthroughs, but by the difference they make in patients’ lives.

Ulrika Årehed Kågström 

Secretary General, The Swedish Cancer Society 

Moments from momentum

Voices from Momentum

About the conference

Momentum brought together policymakers, researchers, healthcare leaders, patient representatives, industry, investors and civil society from across Europe to explore how stronger collaboration across sectors and borders could accelerate progress in cancer research and care. 

Discussions focused on clinical research, regulation, health data, investment and access to innovation, with a shared ambition to ensure that scientific advances reach patients faster and more equitably.

The conference aimed to identify concrete opportunities for collaboration and action, contributing to more effective, sustainable and equitable cancer care across Europe.

About The Swedish Cancer Society 

The Swedish Cancer Society is an independent, non-profit organisation working to beat cancer by funding research, spreading knowledge and influencing decision-makers.  

We are one of the largest funders of cancer research in Sweden. Our work depends on gifts and donations from individuals and companies. Each year, we contribute 1 billion Swedish kronor to leading cancer research.